世界のイノシンプラノベックス市場予測 2020年-2025年

【英語タイトル】Global Inosine Pranobex Market Growth 2020-2025

LP Informationが出版した調査資料(LPI20AP5770)・商品コード:LPI20AP5770
・発行会社(調査会社):LP Information
・発行日:2020年3月27日(※2024年版があります。お問い合わせください)
・ページ数:158
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「イノシンプラノベックスの世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、タブレット、シロップなど、用途別には、免疫調節、抗ウイルス、その他などに区分してまとめた調査レポートです。イノシンプラノベックスのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・イノシンプラノベックスの世界市場概要(サマリー)
・イノシンプラノベックスの企業別販売量・売上
・イノシンプラノベックスの企業別市場シェア
・イノシンプラノベックスの世界市場規模 2015年-2020年:種類別(タブレット、シロップ)
・イノシンプラノベックスの世界市場規模 2015年-2020年:用途別(免疫調節、抗ウイルス、その他)
・イノシンプラノベックスの米州市場規模(アメリカ、カナダ、メキシコなど)
・イノシンプラノベックスのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・イノシンプラノベックスの欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・イノシンプラノベックスの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・イノシンプラノベックス市場の成長要因・課題・動向
・イノシンプラノベックスの世界市場予測 2021年-2025年
・イノシンプラノベックスの米州市場予測(アメリカ、カナダ、メキシコなど)
・イノシンプラノベックスのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・イノシンプラノベックスの欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・イノシンプラノベックスの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・イノシンプラノベックスの世界市場予測:種類別(タブレット、シロップ)
・イノシンプラノベックスの世界市場予測:用途別(免疫調節、抗ウイルス、その他)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Inosine Pranobex market will register a 2.3% CAGR in terms of revenue, the global market size will reach $ 206.5 million by 2025, from $ 188.7 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Inosine Pranobex business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Inosine Pranobex market by type, application, key manufacturers and key regions and countries.

This study considers the Inosine Pranobex value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Tablet
Syrup

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Immunomodulation
Antiviral
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Newport Pharmaceuticals
Meprofarm
Gedeon Richter
Sanofi
Andrómaco
Mochida
Polfarmex
Yung Shin
Sanfer
Alfasigma S.p.A.
Novell Pharmaceutical
Aflofarm

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Inosine Pranobex consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Inosine Pranobex market by identifying its various subsegments.
Focuses on the key global Inosine Pranobex manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Inosine Pranobex with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Inosine Pranobex submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Inosine Pranobex Consumption 2015-2025
2.1.2 Inosine Pranobex Consumption CAGR by Region
2.2 Inosine Pranobex Segment by Type
2.2.1 Tablet
2.2.2 Syrup
2.3 Inosine Pranobex Consumption by Type
2.3.1 Global Inosine Pranobex Consumption Market Share by Type (2015-2020)
2.3.2 Global Inosine Pranobex Revenue and Market Share by Type (2015-2020)
2.3.3 Global Inosine Pranobex Sale Price by Type (2015-2020)
2.4 Inosine Pranobex Segment by Application
2.4.1 Immunomodulation
2.4.2 Antiviral
2.4.3 Other
2.5 Inosine Pranobex Consumption by Application
2.5.1 Global Inosine Pranobex Consumption Market Share by Type (2015-2020)
2.5.2 Global Inosine Pranobex Value and Market Share by Type (2015-2020)
2.5.3 Global Inosine Pranobex Sale Price by Type (2015-2020)

3 Global Inosine Pranobex by Company
3.1 Global Inosine Pranobex Sales Market Share by Company
3.1.1 Global Inosine Pranobex Sales by Company (2018-2020)
3.1.2 Global Inosine Pranobex Sales Market Share by Company (2018-2020)
3.2 Global Inosine Pranobex Revenue Market Share by Company
3.2.1 Global Inosine Pranobex Revenue by Company (2018-2020)
3.2.2 Global Inosine Pranobex Revenue Market Share by Company (2018-2020)
3.3 Global Inosine Pranobex Sale Price by Company
3.4 Global Inosine Pranobex Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Inosine Pranobex Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Inosine Pranobex Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Inosine Pranobex by Regions
4.1 Inosine Pranobex by Regions
4.2 Americas Inosine Pranobex Consumption Growth
4.3 APAC Inosine Pranobex Consumption Growth
4.4 Europe Inosine Pranobex Consumption Growth
4.5 Middle East & Africa Inosine Pranobex Consumption Growth

5 Americas
5.1 Americas Inosine Pranobex Consumption by Countries
5.1.1 Americas Inosine Pranobex Consumption by Countries (2015-2020)
5.1.2 Americas Inosine Pranobex Value by Countries (2015-2020)
5.2 Americas Inosine Pranobex Consumption by Type
5.3 Americas Inosine Pranobex Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Inosine Pranobex Consumption by Regions
6.1.1 APAC Inosine Pranobex Consumption by Regions (2015-2020)
6.1.2 APAC Inosine Pranobex Value by Regions (2015-2020)
6.2 APAC Inosine Pranobex Consumption by Type
6.3 APAC Inosine Pranobex Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Inosine Pranobex by Countries
7.1.1 Europe Inosine Pranobex Consumption by Countries (2015-2020)
7.1.2 Europe Inosine Pranobex Value by Countries (2015-2020)
7.2 Europe Inosine Pranobex Consumption by Type
7.3 Europe Inosine Pranobex Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Inosine Pranobex by Countries
8.1.1 Middle East & Africa Inosine Pranobex Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Inosine Pranobex Value by Countries (2015-2020)
8.2 Middle East & Africa Inosine Pranobex Consumption by Type
8.3 Middle East & Africa Inosine Pranobex Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Inosine Pranobex Distributors
10.3 Inosine Pranobex Customer

11 Global Inosine Pranobex Market Forecast
11.1 Global Inosine Pranobex Consumption Forecast (2021-2025)
11.2 Global Inosine Pranobex Forecast by Regions
11.2.1 Global Inosine Pranobex Forecast by Regions (2021-2025)
11.2.2 Global Inosine Pranobex Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Inosine Pranobex Forecast by Type
11.8 Global Inosine Pranobex Forecast by Application

12 Key Players Analysis
12.1 Newport Pharmaceuticals
12.1.1 Company Information
12.1.2 Inosine Pranobex Product Offered
12.1.3 Newport Pharmaceuticals Inosine Pranobex Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Newport Pharmaceuticals Latest Developments
12.2 Meprofarm
12.2.1 Company Information
12.2.2 Inosine Pranobex Product Offered
12.2.3 Meprofarm Inosine Pranobex Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Meprofarm Latest Developments
12.3 Gedeon Richter
12.3.1 Company Information
12.3.2 Inosine Pranobex Product Offered
12.3.3 Gedeon Richter Inosine Pranobex Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Gedeon Richter Latest Developments
12.4 Sanofi
12.4.1 Company Information
12.4.2 Inosine Pranobex Product Offered
12.4.3 Sanofi Inosine Pranobex Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Sanofi Latest Developments
12.5 Andrómaco
12.5.1 Company Information
12.5.2 Inosine Pranobex Product Offered
12.5.3 Andrómaco Inosine Pranobex Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Andrómaco Latest Developments
12.6 Mochida
12.6.1 Company Information
12.6.2 Inosine Pranobex Product Offered
12.6.3 Mochida Inosine Pranobex Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Mochida Latest Developments
12.7 Polfarmex
12.7.1 Company Information
12.7.2 Inosine Pranobex Product Offered
12.7.3 Polfarmex Inosine Pranobex Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Polfarmex Latest Developments
12.8 Yung Shin
12.8.1 Company Information
12.8.2 Inosine Pranobex Product Offered
12.8.3 Yung Shin Inosine Pranobex Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Yung Shin Latest Developments
12.9 Sanfer
12.9.1 Company Information
12.9.2 Inosine Pranobex Product Offered
12.9.3 Sanfer Inosine Pranobex Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Sanfer Latest Developments
12.10 Alfasigma S.p.A.
12.10.1 Company Information
12.10.2 Inosine Pranobex Product Offered
12.10.3 Alfasigma S.p.A. Inosine Pranobex Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Alfasigma S.p.A. Latest Developments
12.11 Novell Pharmaceutical
12.11.1 Company Information
12.11.2 Inosine Pranobex Product Offered
12.11.3 Novell Pharmaceutical Inosine Pranobex Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Novell Pharmaceutical Latest Developments
12.12 Aflofarm
12.12.1 Company Information
12.12.2 Inosine Pranobex Product Offered
12.12.3 Aflofarm Inosine Pranobex Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Aflofarm Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Inosine Pranobex Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Tablet
Table 5. Major Players of Syrup
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Inosine Pranobex Consumption Market Share by Type (2015-2020)
Table 8. Global Inosine Pranobex Revenue by Type (2015-2020) ($ million)
Table 9. Global Inosine Pranobex Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Inosine Pranobex Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Inosine Pranobex Consumption Market Share by Application (2015-2020)
Table 13. Global Inosine Pranobex Value by Application (2015-2020)
Table 14. Global Inosine Pranobex Value Market Share by Application (2015-2020)
Table 15. Global Inosine Pranobex Sale Price by Application (2015-2020)
Table 16. Global Inosine Pranobex Sales by Company (2017-2019) (K Units)
Table 17. Global Inosine Pranobex Sales Market Share by Company (2017-2019)
Table 18. Global Inosine Pranobex Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Inosine Pranobex Revenue Market Share by Company (2017-2019)
Table 20. Global Inosine Pranobex Sale Price by Company (2017-2019)
Table 21. Global Inosine Pranobex Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Inosine Pranobex Products Offered
Table 23. Inosine Pranobex Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Inosine Pranobex Consumption by Regions 2015-2020 (K Units)
Table 25. Global Inosine Pranobex Consumption Market Share by Regions 2015-2020
Table 26. Global Inosine Pranobex Value by Regions 2015-2020 ($ Millions)
Table 27. Global Inosine Pranobex Value Market Share by Regions 2015-2020
Table 28. Americas Inosine Pranobex Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Inosine Pranobex Consumption Market Share by Countries (2015-2020)
Table 30. Americas Inosine Pranobex Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Inosine Pranobex Value Market Share by Countries (2015-2020)
Table 32. Americas Inosine Pranobex Consumption by Type (2015-2020) (K Units)
Table 33. Americas Inosine Pranobex Consumption Market Share by Type (2015-2020)
Table 34. Americas Inosine Pranobex Consumption by Application (2015-2020) (K Units)
Table 35. Americas Inosine Pranobex Consumption Market Share by Application (2015-2020)
Table 36. APAC Inosine Pranobex Consumption by Countries (2015-2020) (K Units)
Table 37. APAC Inosine Pranobex Consumption Market Share by Countries (2015-2020)
Table 38. APAC Inosine Pranobex Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Inosine Pranobex Value Market Share by Regions (2015-2020)
Table 40. APAC Inosine Pranobex Consumption by Type (2015-2020) (K Units)
Table 41. APAC Inosine Pranobex Consumption Market Share by Type (2015-2020)
Table 42. APAC Inosine Pranobex Consumption by Application (2015-2020) (K Units)
Table 43. APAC Inosine Pranobex Consumption Market Share by Application (2015-2020)
Table 44. Europe Inosine Pranobex Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Inosine Pranobex Consumption Market Share by Countries (2015-2020)
Table 46. Europe Inosine Pranobex Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Inosine Pranobex Value Market Share by Countries (2015-2020)
Table 48. Europe Inosine Pranobex Consumption by Type (2015-2020) (K Units)
Table 49. Europe Inosine Pranobex Consumption Market Share by Type (2015-2020)
Table 50. Europe Inosine Pranobex Consumption by Application (2015-2020) (K Units)
Table 51. Europe Inosine Pranobex Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Inosine Pranobex Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Inosine Pranobex Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Inosine Pranobex Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Inosine Pranobex Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Inosine Pranobex Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Inosine Pranobex Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Inosine Pranobex Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Inosine Pranobex Consumption Market Share by Application (2015-2020)
Table 60. Inosine Pranobex Distributors List
Table 61. Inosine Pranobex Customer List
Table 62. Global Inosine Pranobex Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Inosine Pranobex Consumption Market Forecast by Regions
Table 64. Global Inosine Pranobex Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Inosine Pranobex Value Market Share Forecast by Regions
Table 66. Global Inosine Pranobex Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Inosine Pranobex Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Inosine Pranobex Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Inosine Pranobex Value Market Share Forecast by Type (2021-2025)
Table 70. Global Inosine Pranobex Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Inosine Pranobex Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Inosine Pranobex Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Inosine Pranobex Value Market Share Forecast by Application (2021-2025)
Table 74. Newport Pharmaceuticals Product Offered
Table 75. Newport Pharmaceuticals Inosine Pranobex Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. Newport Pharmaceuticals Main Business
Table 77. Newport Pharmaceuticals Latest Developments
Table 78. Newport Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Inosine Pranobex Manufacturing Base, Sales Area and Its Competitors
Table 79. Meprofarm Product Offered
Table 80. Meprofarm Inosine Pranobex Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. Meprofarm Main Business
Table 82. Meprofarm Latest Developments
Table 83. Meprofarm Basic Information, Company Total Revenue (in $ million), Inosine Pranobex Manufacturing Base, Sales Area and Its Competitors
Table 84. Gedeon Richter Product Offered
Table 85. Gedeon Richter Inosine Pranobex Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. Gedeon Richter Main Business
Table 87. Gedeon Richter Latest Developments
Table 88. Gedeon Richter Basic Information, Company Total Revenue (in $ million), Inosine Pranobex Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Product Offered
Table 90. Sanofi Inosine Pranobex Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Sanofi Basic Information, Company Total Revenue (in $ million), Inosine Pranobex Manufacturing Base, Sales Area and Its Competitors
Table 94. Andrómaco Product Offered
Table 95. Andrómaco Inosine Pranobex Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. Andrómaco Main Business
Table 97. Andrómaco Latest Developments
Table 98. Andrómaco Basic Information, Company Total Revenue (in $ million), Inosine Pranobex Manufacturing Base, Sales Area and Its Competitors
Table 99. Mochida Product Offered
Table 100. Mochida Inosine Pranobex Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. Mochida Main Business
Table 102. Mochida Latest Developments
Table 103. Mochida Basic Information, Company Total Revenue (in $ million), Inosine Pranobex Manufacturing Base, Sales Area and Its Competitors
Table 104. Polfarmex Product Offered
Table 105. Polfarmex Basic Information, Company Total Revenue (in $ million), Inosine Pranobex Manufacturing Base, Sales Area and Its Competitors
Table 106. Polfarmex Main Business
Table 107. Polfarmex Latest Developments
Table 108. Polfarmex Inosine Pranobex Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 109. Yung Shin Product Offered
Table 110. Yung Shin Inosine Pranobex Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. Yung Shin Main Business
Table 112. Yung Shin Latest Developments
Table 113. Yung Shin Basic Information, Company Total Revenue (in $ million), Inosine Pranobex Manufacturing Base, Sales Area and Its Competitors
Table 114. Sanfer Product Offered
Table 115. Sanfer Inosine Pranobex Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 116. Sanfer Main Business
Table 117. Sanfer Latest Developments
Table 118. Sanfer Basic Information, Company Total Revenue (in $ million), Inosine Pranobex Manufacturing Base, Sales Area and Its Competitors
Table 119. Alfasigma S.p.A. Product Offered
Table 120. Alfasigma S.p.A. Inosine Pranobex Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 121. Alfasigma S.p.A. Main Business
Table 122. Alfasigma S.p.A. Latest Developments
Table 123. Alfasigma S.p.A. Basic Information, Company Total Revenue (in $ million), Inosine Pranobex Manufacturing Base, Sales Area and Its Competitors
Table 124. Novell Pharmaceutical Product Offered
Table 125. Novell Pharmaceutical Inosine Pranobex Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 126. Novell Pharmaceutical Main Business
Table 127. Novell Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Novell Pharmaceutical Latest Developments
Table 129. Aflofarm Product Offered
Table 130. Aflofarm Inosine Pranobex Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 131. Aflofarm Main Business
Table 132. Aflofarm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Aflofarm Latest Developments
List of Figures
Figure 1. Picture of Inosine Pranobex
Figure 2. Inosine Pranobex Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Inosine Pranobex Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Inosine Pranobex Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Tablet
Figure 7. Product Picture of Syrup
Figure 8. Global Inosine Pranobex Consumption Market Share by Type (2015-2020)
Figure 9. Global Inosine Pranobex Value Market Share by Type (2015-2020)
Figure 10. Inosine Pranobex Consumed in Immunomodulation
Figure 11. Global Inosine Pranobex Market: Immunomodulation (2015-2020) (K Units)
Figure 12. Global Inosine Pranobex Market: Immunomodulation (2015-2020) ($ Millions)
Figure 13. Inosine Pranobex Consumed in Antiviral
Figure 14. Global Inosine Pranobex Market: Antiviral (2015-2020) (K Units)
Figure 15. Global Inosine Pranobex Market: Antiviral (2015-2020) ($ Millions)
Figure 16. Inosine Pranobex Consumed in Other
Figure 17. Global Inosine Pranobex Market: Other (2015-2020) (K Units)
Figure 18. Global Inosine Pranobex Market: Other (2015-2020) ($ Millions)
Figure 19. Global Inosine Pranobex Consumption Market Share by Application (2015-2020)
Figure 20. Global Inosine Pranobex Value Market Share by Application (2015-2020)
Figure 21. Global Inosine Pranobex Sales Market Share by Company in 2017
Figure 22. Global Inosine Pranobex Sales Market Share by Company in 2019
Figure 23. Global Inosine Pranobex Revenue Market Share by Company in 2017
Figure 24. Global Inosine Pranobex Revenue Market Share by Company in 2019
Figure 25. Global Inosine Pranobex Sale Price by Company in 2019
Figure 26. Global Inosine Pranobex Consumption Market Share by Regions 2015-2020
Figure 27. Global Inosine Pranobex Value Market Share by Regions 2015-2020
Figure 28. Americas Inosine Pranobex Consumption 2015-2020 (K Units)
Figure 29. Americas Inosine Pranobex Value 2015-2020 ($ Millions)
Figure 30. APAC Inosine Pranobex Consumption 2015-2020 (K Units)
Figure 31. APAC Inosine Pranobex Value 2015-2020 ($ Millions)
Figure 32. Europe Inosine Pranobex Consumption 2015-2020 (K Units)
Figure 33. Europe Inosine Pranobex Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Inosine Pranobex Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Inosine Pranobex Value 2015-2020 ($ Millions)
Figure 36. Americas Inosine Pranobex Consumption Market Share by Countries in 2019
Figure 37. Americas Inosine Pranobex Value Market Share by Countries in 2019
Figure 38. Americas Inosine Pranobex Consumption Market Share by Type in 2019
Figure 39. Americas Inosine Pranobex Consumption Market Share by Application in 2019
Figure 40. United States Inosine Pranobex Consumption Growth 2015-2020 (K Units)
Figure 41. United States Inosine Pranobex Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Inosine Pranobex Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Inosine Pranobex Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Inosine Pranobex Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Inosine Pranobex Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Inosine Pranobex Consumption Market Share by Countries in 2019
Figure 47. APAC Inosine Pranobex Value Market Share by Regions in 2019
Figure 48. APAC Inosine Pranobex Consumption Market Share by Type in 2019
Figure 49. APAC Inosine Pranobex Consumption Market Share by Application in 2019
Figure 50. China Inosine Pranobex Consumption Growth 2015-2020 (K Units)
Figure 51. China Inosine Pranobex Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Inosine Pranobex Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Inosine Pranobex Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Inosine Pranobex Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Inosine Pranobex Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Inosine Pranobex Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Inosine Pranobex Value Growth 2015-2020 ($ Millions)
Figure 58. India Inosine Pranobex Consumption Growth 2015-2020 (K Units)
Figure 59. India Inosine Pranobex Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Inosine Pranobex Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Inosine Pranobex Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Inosine Pranobex Consumption Market Share by Countries in 2019
Figure 63. Europe Inosine Pranobex Value Market Share by Countries in 2019
Figure 64. Europe Inosine Pranobex Consumption Market Share by Type in 2019
Figure 65. Europe Inosine Pranobex Consumption Market Share by Application in 2019
Figure 66. Germany Inosine Pranobex Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Inosine Pranobex Value Growth 2015-2020 ($ Millions)
Figure 68. France Inosine Pranobex Consumption Growth 2015-2020 (K Units)
Figure 69. France Inosine Pranobex Value Growth 2015-2020 ($ Millions)
Figure 70. UK Inosine Pranobex Consumption Growth 2015-2020 (K Units)
Figure 71. UK Inosine Pranobex Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Inosine Pranobex Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Inosine Pranobex Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Inosine Pranobex Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Inosine Pranobex Value Growth 2015-2020 ($ Millions)
Figure 76. Spain Inosine Pranobex Consumption Growth 2015-2020 (K Units)
Figure 77. Spain Inosine Pranobex Value Growth 2015-2020 ($ Millions)
Figure 78. Middle East & Africa Inosine Pranobex Consumption Market Share by Countries in 2019
Figure 79. Middle East & Africa Inosine Pranobex Value Market Share by Countries in 2019
Figure 80. Middle East & Africa Inosine Pranobex Consumption Market Share by Type in 2019
Figure 81. Middle East & Africa Inosine Pranobex Consumption Market Share by Application in 2019
Figure 82. Egypt Inosine Pranobex Consumption Growth 2015-2020 (K Units)
Figure 83. Egypt Inosine Pranobex Value Growth 2015-2020 ($ Millions)
Figure 84. South Africa Inosine Pranobex Consumption Growth 2015-2020 (K Units)
Figure 85. South Africa Inosine Pranobex Value Growth 2015-2020 ($ Millions)
Figure 86. Israel Inosine Pranobex Consumption Growth 2015-2020 (K Units)
Figure 87. Israel Inosine Pranobex Value Growth 2015-2020 ($ Millions)
Figure 88. Turkey Inosine Pranobex Consumption Growth 2015-2020 (K Units)
Figure 89. Turkey Inosine Pranobex Value Growth 2015-2020 ($ Millions)
Figure 90. GCC Countries Inosine Pranobex Consumption Growth 2015-2020 (K Units)
Figure 91. GCC Countries Inosine Pranobex Value Growth 2015-2020 ($ Millions)
Figure 92. Global Inosine Pranobex Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 93. Global Inosine Pranobex Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 94. Americas Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 95. Americas Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 96. APAC Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 97. APAC Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 98. Europe Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 99. Europe Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 100. Middle East & Africa Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 101. Middle East & Africa Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 102. United States Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 103. United States Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 104. Canada Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 105. Canada Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 106. Mexico Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 107. Mexico Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 108. Brazil Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 109. Brazil Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 110. China Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 111. China Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 112. Japan Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 113. Japan Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 114. Korea Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 115. Korea Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 116. Southeast Asia Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 117. Southeast Asia Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 118. India Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 119. India Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 120. Australia Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 121. Australia Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 122. Germany Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 123. Germany Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 124. France Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 125. France Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 126. UK Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 127. UK Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 128. Italy Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 129. Italy Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 130. Russia Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 131. Russia Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 132. Spain Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 133. Spain Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 134. Egypt Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 135. Egypt Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 136. South Africa Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 137. South Africa Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 138. Israel Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 139. Israel Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 140. Turkey Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 141. Turkey Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 142. GCC Countries Inosine Pranobex Consumption 2021-2025 (K Units)
Figure 143. GCC Countries Inosine Pranobex Value 2021-2025 ($ Millions)
Figure 144. Newport Pharmaceuticals Inosine Pranobex Market Share (2018-2020)
Figure 145. Meprofarm Inosine Pranobex Market Share (2018-2020)
Figure 146. Gedeon Richter Inosine Pranobex Market Share (2018-2020)
Figure 147. Sanofi Inosine Pranobex Market Share (2018-2020)
Figure 148. Andrómaco Inosine Pranobex Market Share (2018-2020)
Figure 149. Mochida Inosine Pranobex Market Share (2018-2020)
Figure 150. Polfarmex Inosine Pranobex Market Share (2018-2020)
Figure 151. Yung Shin Inosine Pranobex Market Share (2018-2020)
Figure 152. Sanfer Inosine Pranobex Market Share (2018-2020)
Figure 153. Alfasigma S.p.A. Inosine Pranobex Market Share (2018-2020)
Figure 154. Novell Pharmaceutical Inosine Pranobex Market Share (2018-2020)
Figure 155. Aflofarm Inosine Pranobex Market Share (2018-2020)


★調査レポート[世界のイノシンプラノベックス市場予測 2020年-2025年] (コード:LPI20AP5770)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のイノシンプラノベックス市場予測 2020年-2025年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆